Ledger.Open graph →
SEC Form D · filed October 29, 2014

AILERON THERAPEUTICS INC

Offering
$33.0M
Sold
$19.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

John H. Mcarthur · Cambridge, MADirectorBrian M. Gallagher, Jr · Cambridge, MADirectorReinhard J. Ambros · Cambridge, MADirectorJoseph A. Yanchik Iii · Cambridge, MAExec · DirectorScott L. Kapnick · Cambridge, MADirectorSeth L. Harrison · Cambridge, MADirectorArmen H. Shanafelt · Cambridge, MADirectorEnrico H. Petrillo · Cambridge, MADirectorChristina Yeung · San Francisco, CADirectorDhruvkaran Mehta · San Francisco, CAExec · DirectorJoshua Weissburg · San Francisco, CAExec · DirectorFox Point Capital Management LLC · New York, NYDirectorFox Point Performance LP · New York, NYDirectorShober Holdings LLC · New York, NYDirectorBill Burgess · Chicago, ILDirectorGreg Buchholz · Chicago, ILDirectorChuck Teubner · Chicago, ILDirectorWilliam Elmore · Chicago, ILDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗